Small-Cap Grace Therapeutics Touts Positive Data From Brain Hemorrhage Study – Grace Therapeutics (NASDAQ:GRCE)

Small-Cap Grace Therapeutics Touts Positive Data From Brain Hemorrhage Study – Grace Therapeutics (NASDAQ:GRCE)

On Monday, Grace Therapeutics, Inc. GRCE, formerly b, announced topline data from its Phase 3 STRIVE-ON…

Continue Reading